FemTech company focused on vaginal health
About Pharmiva
Pharmiva is a Swedish company active within FemTech that develops innovative and antibiotic-free treatments to improve vaginal health. The Company’s first product, Vernivia®, is a CE-approved, over-the-counter vaginal mousse for the treatment of bacterial vaginosis (BV); a common vaginal infection that affects 1 in 3 women between the ages of 14–49 years. Vernivia® vaginal mousse provides women with an effective treatment that cures the infection and provides a rapid symptom relief without problematic side-effects that are associated with current antibiotic treatments. The launch of Vernivia®, through Swedish pharmacies, marks the first step towards Pharmiva’s goal of becoming a global FemTech company, with a broad portfolio of antibiotic-free products for vaginal health. Together, the employees at Pharmiva have broad experience and knowledge from the life science sector, in the fields of therapeutics and product development.
Pharmiva is listed on Nasdaq First North Growth Market, for more information visit www.pharmiva.com
The partner Fondkommission AB is the Company’s Certified Adviser, (telephone +46 317 612 230) , www.partnerfk.se
- 1177, Bacterial vaginosis, What can I do myself?
Carlsquare Equity Research sees positive signals for Pharmiva’s product Vernivia and publishes update of its initial analysis
To read the update from Carlsquare Equity Research, click here.
Management team
Anna Linton
General info:
Anna was born in 1971 and holds a B.Sc Pharmacology from Uppsala University.
Experience:
Anna has over 20 years of experience in the development, commercialization and distribution of pharmaceuticals. During the last ten years, she has been responsible for Life Science companies in an expansive phase. Anna comes most recently from a role as CEO of Unimedic Group which develops and distributes specialist medicines, the company is also a contract manufacturer of medicines. Previous assignments include positions such as Nordic Head of Recordati and Nordic CEO of Grünenthal, as well as leading positions in commercialization and sales at Abbott, Wyeth and Pfizer.
Andra pågående uppdrag:
Milmed Unico AB (commissioner)
Holdings in Pharmiva AB:
70 106 shares
Per-Ola Forsberg
General info:
Per-Ola was born in 1961 and holds a degree in Business and Economics from Lund University, Sweden.
Experience:
Per-Ola has over 25 years of experience in the pharmaceutical and biotechnology industry, and previous assignments include roles as CFO at Idogen, LIDDS, Lund University Bioscience and Probi. At Probi, he acted as Vice President, over a period, and was responsible for the Company’s business operations. Previous positions include Controller at Rexam Beverage Can Fosie, Head of Administration at PolyPeptide Laboratories and Subsidiary of Ferring. Per-Ola has also contributed to three IPOs. His current role is as CFO at Pharmiva.
.
Other ongoing assignments
Rapidsrock AB (own consulting company)
Holdings in Pharmiva AB:
35 832 shares
Board of Directors
Malte Zaunders
General info:
Malte was born in 1975 and holds a M.Sc. in Engineering from Chalmers University of Technology, Sweden and London Business School.
Experience:
Malte has been involved in Pharmiva since founding. He has more than 20 years of advisory and investment experience from JP Morgan and Zolfo Cooper (London, UK), among others. Currently, he is a Managing Partner at AZ Growth Capital and Hortus Group.
Other ongoing assignments
AZ Growth Capital AB (Chairman), Hortus Group AB (director), Link Group Europe AB (director), Crunchfish AB (director), Adrenaline Travel AB (director).
Holdings in Pharmiva AB:
569 841 shares directly and 53 941 through endowment insurance
Independent:
Not independent in relation to the Company, independent in relation to the owners .
Ingrid Atteryd Heiman
General info:
Ingrid was born in 1958 and holds a M.Sc. in Economics from Lund University, Sweden and an MBA in International Business from Uppsala University, Sweden and StyrelseAkademiens ordförandeutbildning.
Experience:
Ingrid has more than 15 years of experience in the self-care market, as CEO and Chairman of Svensk Egenvård and its European counterpart, and as CEO and Chairman of Ellen AB. Ingrid also brings experience from several listed life science companies on the Nasdaq First North Growth Market and Spotlight Stock Market
Other ongoing assignments:
Redwood Pharma AB (director), CarpoNovum AB (director), VitalSign AB (director), Parkinson Research Foundation (director and administrator officer).
Holdings in Pharmiva AB:
2 000 shares
Independent:
Ingrid is independent in relation to the Company and its management, as well as to the Company’s major shareholders.
Ulf Blom
General info:
Ulf was born in 1965 and holds a M.Sc. in Economics and is a certified pharmaceutical consultant with courses in strategy, leadership, governance and due diligence.
Experience:
Ulf has more than 20 years of experience from pharmaceutical companies such as Novo Nordisk, Astra Zeneca and ALK AS. He has spent the last 13 years in the biotech industry as EVP Marketing & Innovation at the Nasdaq-listed company Enzymatica at Ideon Science Park in Lund, which he also co-founded. Currently, he is a member of the Board of Enzymatica Care AB and previously held a position in listed Idogen AB. He also owns a financial company, MedZyme Invest AB.
Other ongoing assignments
Enzymatica AB (EVP Marketing & Innovation), Enzymatica Care AB (director)
Holdings in Pharmiva AB:
7 815 shares through companies
Independent:
Ulf is independent in relation to the Company and its management, as well as to the Company’s major shareholders
Kristina Ingvar
General info:
Kristina was born in 1972 and holds a Bachelor of Science in Medicine from Lund University and a Certificate in Marketing from Executive Foundation Lund.
Experience:
Kristina has over 20 years of experience in Life Science. She works as Head of Quality and Registration in the management team at Bonesupport AB, a medical technology company active in orthopaedics listed on Nasdaq Stockholm. Previous experiences include global leadership roles in quality and registration at Novo Nordisk A/S, a multinational world-leading diabetes pharmaceutical company listed on Nasdaq Copenhagen and the New York Stock Exchange. Kristina also has experience in marketing and product development.
Other ongoing assignments:
Tanketanken AB (CEO, director), Gamify AB (director), AB Stillingsöns Intressenter (Lay auditor)
Holdings in Pharmiva AB:
40 000 shares
Independent:
Kristina is independent in relation to the Company and its management, as well as to the Company’s major shareholders
Employees
Medical advisors
Helena Kopp Kallner
Senior Physician at Danderyd Hospital,
Associate Professor at Karolinska Institutet
Emma Karling Widsell
Midwife at Danderyd Hospital maternity ward. Together with Carolina Tristen, she makes a podcast about involuntary childlessness, “Ivf-podden”, and has been a regular expert on the subject in TV4 Nyhetsmorgon.
Rebecka Kaplan Sturk
Specialist in obstetrics/gynaecology, certified nutritionist, Acting Editor in Chief of Praktisk Medicinnekologi , diplomerad kostrådgivare, Tf. chefredaktör Praktisk Medicin.
Per-Göran Larsson
Associate Professor and Senior Physician
Isis Amer Wåhlin
Founder and CEO 2Heal Medical
Senior researcher Karolinska Institutet and RISE (Research Institute of Sweden)
Senior physician in obstetrics/gynaecology
Christina Östberg Lloyd
Specialist in obstetrics/gynaecology
Senior Vice President Reproductive Medicine & Maternal Health Ferring Pharmaceuticals
Work for us
VACANCIES
We currently have no vacancies.
Contact us
Pharmiva AB
Scheelevägen 4
223 81 Lund
For share related questions please contact: ir@pharmiva.com
Have you experienced a side effect from our product Vernivia? Please contact us at: complaint@vernivia.com
Product website: